Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States.
Saved in:
| Title: | Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States. |
|---|---|
| Authors: | Feldstein LR; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Ruffin J; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Wiegand RE; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Borkowf CB; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., James-Gist J; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Babu TM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Briggs-Hagen M; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Chappell J; Vanderbilt University Medical Center, Nashville, Tennessee., Chu HY; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Englund JA; Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, Washington., Kuntz JL; Kaiser Permanente Center for Health Research, Portland, Oregon., Lauring AS; Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Lo N; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Carone M; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Lockwood C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Martin ET; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan., Midgley CM; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Monto AS; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan., Naleway AL; Kaiser Permanente Center for Health Research, Portland, Oregon., Ogilvie T; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Saydah S; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Schmidt MA; Kaiser Permanente Center for Health Research, Portland, Oregon., Schmitz JE; Vanderbilt University Medical Center, Nashville, Tennessee., Smith N; Kaiser Permanente Center for Health Research, Portland, Oregon., Sohn I; Vanderbilt University Medical Center, Nashville, Tennessee., Starita L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee., Weil AA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Grijalva CG; Vanderbilt University Medical Center, Nashville, Tennessee. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2025 Apr 15; Vol. 231 (4), pp. e743-e753. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiaf007 |
